hcp.obgyn.net Members: Login | Register
OBGYN.net Recommended Medical Sites Medline Drugs

Powered by SearchMedica

 
  • Home
  • News
  • Blogs
  • Calendar
  • Conditions and Procedures
  • Conferences
  • Tutorials
  • Forum
  • Ultrasound
  • Buyer's Guide


OBGYN.net.
 

Premenstrual Syndrome, Part 2

By Tori Hudson, ND | November 14, 2011
Reprinted with permission of Femalepatient

As mentioned in part 1, 80% of women experience premenstrual emotional or physical changes, whereas only about 20% to 40% of these women have difficulties as a result. A much smaller number, about 2.5% to 5%,2 feel it has a significantly negative impact on their lives, to the point where work, relationships, and home life are jeopardized. Nutrition, exercise, and nutritional supplementation are natural approaches in the management and treatment of premenstrual syndrome (PMS). What follows is a guide to the botanicals and natural hormones that have been investigated that also help symptoms of PMS.

BOTANICALS
Chaste Tree (Vitex agnus castus)

Chaste tree berry has been seen by many alternative practitioners as one of the most important herbs to treat PMS. The effect of chaste tree is on the hypothalamus-hypophysis axis. It increases secretion of luteinizing hormone and also has an effect that favors progesterone(Drug information on progesterone). Two surveys were done covering 1,542 women with PMS who had been treated with a German liquid extract of chaste tree for periods of up to 16 years.3 The average dose was 42 drops daily.

Effectiveness as recorded by the patients' doctors was either very good, good, or satisfactory in 92% of the cases. Comparable dosing in standardized capsules are one capsule at 175 mg if standardized to 0.75% agnuside, or one capsule at 215 mg if standardized to 0.6% aucubin. No certain comparable dose of straight chaste tree tincture is known, but most practitioners would use 1 to 2 teaspoons daily.

The newest study was a clinical trial on 170 women with PMS,4 the most well-designed trial yet studying the efficacy of chaste tree in women's health. Women were assigned to take either a tablet containing an extract of chaste tree berry (20 mg) or a placebo tablet once daily for 3 months. Subjective reporting of irritability, mood changes, anger, headache, breast tenderness, and bloating were recorded. At the end of the 3 months, women taking chaste tree reported a 52% reduction in PMS symptoms versus 24% reduction for those in the placebo group. Women in the chaste tree group reported their significant reduction in all symptoms except for bloating before the menses. This well designed clinical trial confirms the previous findings of the uncontrolled studies.

There have been less positive chaste tree and PMS studies. In one trial, dramatic improvements were seen during the first treatment cycle with chaste tree, and that improvement was maintained for the next two remaining cycles.5 However, this pattern also occurred in the placebo group. Twenty symptoms were assessed but only one improved significantly more than in the placebo group.

Ginkgo (Ginkgo biloba)
A double-blind, placebo-controlled study was done in 1993 to determine the effectiveness of ginkgo extract on PMS symptoms. One hundred sixty-five women were studied and received either a ginkgo extract of 24% ginkgo flavonglycoside content at 80 mg twice daily or a placebo from day 16 of their cycle to day 5 of the next cycle. The ginkgo extract was effective against the congestive symptoms of PMS, particularly breast pain or tenderness6 but not other PMS symptoms.

St. John's Wort
A prospective, open, uncontrolled, observational pilot study using St. John's wort standardized extract, 300 mg three times daily, was investigated to establish a hypothesis and to test methods for a future randomized controlled trial.7 Nineteen women with PMS underwent a preliminary screening interview and completed a daily symptom rating for one cycle. After taking the St. John's wort for two complete menstrual cycles, daily symptoms were rated using the Hospital Anxiety and Depression scale and a modified Social Adjustment Scale. The degree of improvement in overall PMS scores between baseline and the end of the trial was 51%, with more than two thirds of the sample demonstrating at least a 50% decrease in symptom severity. The mood subscale showed the most improvement (57%), and the symptoms with the greatest reductions in scores were crying (92%), depression (85%), confusion (75%), feeling out of control (72%), nervous tension (71%), anxiety (69%), and insomnia (69%).

Additional Herbs
Many other herbs that have not been subjected to scientific research for the treatment of PMS have also been used successfully by women and practitioners for decades. These include many species of wild yam, licorice root, dong quai, and black cohosh. Angelica or dong quai has been primarily regarded as a "female" remedy and used to treat menopausal symptoms, menstrual cramps, abnormal uterine bleeding, and premenstrual problems. No one knows exactly how dong quai works in addressing premenstrual symptoms although it is known to aid in uterine relaxation, as is needed with premenstrual uterine cramping. Licorice may be useful in treating PMS because of its ability to raise progesterone levels. Although abnormal hormone levels in women with PMS is not yet a proven finding, many women respond to either more progesterone or herbs that help the body to raise its own progesterone level. Black cohosh has been shown to reduce premenstrual depression, anxiety, tension, and mood swings in a study done back in the 1960s.8 Other plants are used because of their benefit with specific symptoms, and do have scientific efficacy and documentation; for example, kava extract is used for anxiety, St. John's wort for depression, dandelion leaf for water weight gain, valerian for sleep problems, and lemon balm for herpes eruptions. You will often find one or more of these herbs in a combination herbal and nutritional product that has been specifically formulated for PMS symptoms relief.

NATURAL HORMONES
Natural Progesterone
Perhaps no other PMS therapy has been the target of so much controversy as natural progesterone. This has as much to do with the lack of agreement and scientific research to support a unified theory as to the cause of PMS as it has to do with the efficacy of natural progesterone itself. Green and Dalton advanced a theory in the 1950s that PMS was caused by unopposed estrogen during the luteal phase of the menstrual cycle. Dalton reported in her book, the Premenstrual Syndrome and Progesterone Therapy9 that she has used natural progesterone via injections (25-100 mg daily), vaginal and rectal suppositories (400-1,600 mg daily), and subcutaneous pellets (500-1,600 mg every 3-12 months) with results as good as complete relief of PMS symptoms in 83% of women.10 There have been several studies that demonstrate a lack of efficacy of rectal and vaginal suppositories in the treatment of PMS. In 1979, Sampson conducted the first placebo-controlled, double-blind trial of rectal-vaginal progesterone. There was no significant difference between progesterone at either a 200 mg dose twice daily by suppository or pessary, rectally or vaginally, and placebo.11 In 1983, Van der Meer et al published results of a randomized clinical trial of rectal progesterone. Twenty patients received 200 mg progesterone twice daily. Of the 13 who completed the trial, none showed a difference in psychologic or somatic symptoms.12 In 1986, Maddocks et al restudied vaginal progesterone for PMS; 200 mg twice daily was delivered vaginally and compared with placebo in a double-blind trial.13 There were 48 women who entered the study and only 20 completed it. The somatic and affective symptoms were the same for both progesterone and placebo. In 1990, Freeman also found progesterone in vaginal and rectal suppositories to be ineffective.14 Although the suppository method of delivering natural progesterone for PMS has not held up to scientific scrutiny, oral micronized natural progesterone has. A controlled study by Dennerstein and colleagues in 1985 found an overall beneficial effect using 300 mg/day (100 mg in the morning; 200 mg in the evening) for 10 days of each menstrual cycle starting 3 days after ovulation.15 A statistically significant improvement was noted in anxiety, depression, distress, swelling, fluid retention, and hot flushes. No effect was seen in libido or restlessness. One subject experienced a severe premenstrual migraine as a side effect.

Natural progesterone creams have not been subjected to scientific scrutiny for PMS although tens of thousands of women can attest to their benefit. Progesterone cream is commonly used in over-the-counter products that contain up to as much as 400 mg of natural progesterone per ounce. Using 1/4 teaspoon per dose will deliver approximately 20 mg of United States Pharmacopeia natural progesterone, the same progesterone that is in oral micronized progesterone. Applying 1/4 to 1/2 teaspoon twice daily starting at midcycle and continuing for 12 days, stopping the day before the menses is a typical use. The best sites for rubbing in the cream include the palms, inner upper arms, chest, and inner thighs.

Prior to the use of selective serotonin reuptake inhibitors (SSRIs) for the treatment of PMS, conventional mainstream medicine has not been able to offer women a known cause for PMS nor has it been able to offer a management approach short of pharmaceuticals with often as many side effects as relief. Self-care with natural therapies has been the dominant method of how women manage PMS. Women have clearly taken this monthly familiar problem into their own hands and more often than not have determined what works for them. The astute and well educated practitioner can offer additional therapies and clinical insights to help most of the remaining women with more severe symptoms who need more specific and effective dosing regimens of natural substances as well as a well thought out comprehensive approach. Select individuals with clearly severe (especially mood and behavioral) symptoms can then be prescribed SSRIs. Treating PMS with a natural and holistic approach often serves as a touchstone for motivating women to make lifestyle changes that have a positive cascade effect on their general health.

Part 1, Exercise and Nutrition

 

Join the Conversation

Want to join the conversation? Just sign in or register today to become part of our growing, online community.





Tori Hudson, ND, is a professor, National College of Naturopathic Medicine, and director, A Woman's Time, PC, Portland, Ore.

REFERENCES
1. Hudson T. Premenstrual Syndrome. The Female Patient. 2002;27(5):47-49,59.
2. American College of Obstetrics and Gynecology (ACOG). Committee opinion. Int J Gynecol Obstet. 1995;50:80.
3. Dittmar F. Das pramenstruelle Spannungssyndrome. J Gynakol. 1989; 5(6):4-7.
4. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomized, placebo controlled study. BMJ. 2001;20:134-137.
5. Turner S, Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study.Complement Ther Med. 1993;1:73-77.
6. Tamborini A, Taurelle R. "Value of standardized Ginkgo biloba extract in the management of congestive symptoms of premenstrual syndrome." Gynecol Obstet. 1993;88: 447-457.
7. Stevinson C, Ernst E. A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome. Br J Obstet Gynaecol. 2000;107:870-876.
8. Schildge E. Essay on the treatment of premenstrual and menopausal mood swings and depressive states. Rigelh Biol Umsch. 1964;19(2):18-22
9. Dalton K. The Premenstrual Syndrome and Progesterone Therapy. 2nd ed. Chicago, Ill: Year Book Medical Publishers; 1976.
10. Keye W Jr. Medical treatment of premenstrual syndrome. Can J Psychiatry. 1985;30:483-487.
11. Sampson G. Premensrual syndrome: a double-blind controlled trial of progesterone and placebo. Br J Psychiatry. 1979;135:209.
12. Van Der Meer Y, Benedek-Jaszmann L, Van Loenen A. Effect of high-dose progesterone on the pre-menstrual syndrome; a double-blind cross-over trial. J Psychosomatic Obstet Gynaecol. 1983;2:220.
13. Maddocks S, Hahn P, Moller F, et al. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am J Obstet Gynecol. 1986;154:573.
14. Freeman E, Rickels K, Sonheimer S, Polansky M. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA. 1990;264:349-353.
15. Dennerstein L, Spencer-Gardner C, Gotts, G et al. Progesterone and the premenstrual syndrome: a double blind crossover trial. Br Med J. 1985;290:1617-1621.


TopicIndex

 

Adhesions
Breast Health and Breast Care
Contraception
Electronic Health Records (EHRs)
Endometriosis
Fetal Monitoring
Fibroids
Gestational Diabetes
Gynecologic Oncology
Hysterectomy
Infertility
In Vitro Fertilization (IVF)
Laparoscopy
Malpractice

  Menopause
Osteoporosis

Polycystic Ovary Syndrome
Postpartum Depression
Pelvic Pain
Premenstrual Syndrome/Premenstrual Dysphoric Disorder (PMS/PMDD)
Pregnancy and Birth
Sex-related Issues
Ultrasound
Urogynecology
Uterine (Endometrial) Polyps
Weight Management
Young Women

 

MedicaForums

The Plan B Debacle Continues
Medica Forums - 6/17/13
First, Plan B was only available OTC to women age 17 and up. In April, a judge ordered that it be made available to women of all ages. Now, an appeals court judge has stayed an order that would make a one-dose version of the emergency contraception available to all ages, while allowing the two-dose drug to be sold OTC without restriction. What do you make of all this?
muscle pain relief in Hong Kong
Medica Forums - 6/15/13
muscle pain relief in Hong kong
eToims is a non-invasive pain therapy treatment for individuals desiring general physical health maintenance and enhancement or relief from chronic pain.Back pain is often caused or aggravated by bad or worn-out mattresses. A new pressure-relieving mattress and pillow can make a huge difference. It can support your back, shoulders and neck where it needs it most and thereby help you sleep in a better position, relieving pressure points and back pain. For more information on pressure relieving mattresses and pillows click here.For more information visit us at- Email-info@etoims.com,Contact- +1 215-387-0550.
Whatever Happened To OB-GYN-L?
Medica Forums - 6/12/13
For the past few months, I have not received any posts on the listserv OB-GYN-L. I would get daily posts in my e-mail. Where has it gone, what has happened to it? What can I do to get back on the list?

If anybody has any information, send me a note at:

dean@thehuffpeople.net


Dean Huffman
Pregnancy categories of drugs
Medica Forums - 6/6/13
Pregnant woman and the newborn infant in breast feeding both of them need safety. So, caution in use of drugs in pregnancy and during lactation is mandatory. The knowledge of risk-benefit ratio of different drugs should be in mind of the doctor while prescribing a pregnant or lactating lady.Definitions of Pregnancy categories of drugs and a table showing pregnancy categories of drugs and safety of drugs in lactation are given here.

Definitions of Pregnancy categories of drugs:

On the basis of the potentiality for producing birth defects drugs in pregnancy are grouped into 1 of 5 categories which are A,B, C, D and X. Drugs of class A and B are considered safe and can be used routinely.

Pregnancy Category A : Controlled studies in pregnant women fail to detect risk to the fetus in the first trimester and no evidence of risk in later trimesters. The possibility of harm to the fetus appears remote by using the drugs of pregnancy category A.

Pregnancy Category B : Presumed safety on the basis of animal studies, with no controlled study in pregnant women, or animal studies have shown an adverse effect which was not confirmed in controlled studies in women in the first trimester and there is no evidence of risk to the fetus in later trimesters.

Pregnancy Category C : Studies in women and animals are not available or studies in animals have shown adverse effects on the fetus and there is no controlled study in women. Drugs should be given in pregnancy only if the potential benefits justify the potential risk to the fetus.

Pregnancy Category D : There is positive evidence of risk to the human fetus (unsafe), however in a life-threatening illness the potential risk may be justified if there are no other alternatives.

Pregnancy Category X : Highly unsafe: risk of use outweighs any potential benefit. Drugs in this category are contraindicated in pregnant women or in a woman who may become pregnant. To get more please visit -
http://medicalforall.net/drugs-pregnancy-lactation/
Attendance in L and D
Medica Forums - 6/1/13
Recently, I had the occasion to review a case of a term primigravida with PROM in a private hospital (no housestaff or in house obstetricians). She was seen by an obstetrician soon after arrival, evaluated, and pitocin induction begun.

She did not deliver for around 29 hours after admission, and the delivering obstetrician (a different physician) was physically present during the last 2 hours of labor prior to delivery.

Simply put, while the two involved obstetricians were in communication by phone with the nursing staff throughout labor (separately as their "shifts" did not overlap), no one actually came to the bedside and wrote a note) from admission until around 2 hours before delivery.

Medical staff bylaws call for a daily progress note; this bylaw was easily met.

In reviewing the case, it did not "feel good" that no one came to the bedside.

My questions:

1. Does anyone have or know of any guidelines to mandate such bedside attendance? Of course, we all hope that the involved physicians would not need said guidelines.
2. Does anyone have a suggestion of hospital/nursing protocols? Simply, in this case I would like to have had a charge nurse or bedside nurse simply say, "Hey, no one has been by for a while. What's up?"

Garry



EducationalTutorials


Educational Tutorial: Complications of Laparoscopy
February 7, 2012

There are a variety of complications that can occur during laparoscopic surgery. In this tutorial learn some of the complications and tips to avoid them.

Educational Tutorial: Low Molecular Weight Heparin in Recurrent Abortions
January 17, 2012

Review information on low molecular weight heparin in recurrent miscarriages in this educational tutorial.

Laparoscopy in Infertility An Evidence Based View
October 14, 2011

Thromboembolic Disease in Pregnancy and Puerperium
September 14, 2011

What to Know About: Prenatal Care, Labor and Delivery
August 17, 2011

CaseStudies


Fetal Abdomen with Gallbladder Calculi
Dr. Muktachand and Dr. Trupti , September 27, 2011

B mode and 3D Ultrasound images of a fetal abdomen (35wks) revealing gallbladder calculi

Sacrococcygeal Teratoma?
Dr. Jaydeep , September 14, 2011

This case study shows a 26 week gestation with a cystic mass close to the sacrum.

Fetal Cardiac Anomalies
Joshua Abbott Copel, MD OBGYN.net Advisory Board Member , July 19, 2011

CC is a 31 year old primigravida who was referred for ultrasound at a community hospital due to suspected cardiac anomalies noted on a screening sonogram at her doctor's office. Due to concern about a probable cardiac abnormality an amniocentesis was performed at the local hospital.

Single Umbilical Artery Color Doppler
Abana Cerekja , June 15, 2011

Single umbilical artery color doppler, transverse scan of urinary bladder shows single umbilical artery (left), transverse section of umbilical cord showing only two vessels: one vein and one artery (right).

Ductus Venosus Spectral Waveform
Dr. Joe Antony , June 15, 2011

Normal 35 week pregnancy

FromPhysiciansPractice

Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

  • On This Site
  • Most Emailed
  • On This Topic

MostPopular

  • The Relationship Between Placental Location and Fetal Gender (Ramzi’s Method)

    JUN 14 2011 OBGYN.NET READ >>

  • Daily Dx: Middle-Aged Woman with Non-specific Pelvic Pain

    JUN 4 2013 OBGYN.NET READ >>

  • Daily Dx: Three-Vessel View of a Fetal Heart

    MAY 28 2013 OBGYN.NET READ >>

  • Daily Dx: A Child with Dysuria and Pelvic Pain

    JUN 11 2013 OBGYN.NET READ >>

  • The Best Screening Strategies for Cervical Cancer

    JUN 7 2013 OBGYN.NET READ >>

MostPopular

  • FDA Warning: Don’t Use Magnesium Sulfate to Stop Pre-term Labor

    JUN 6 2013OBGYN.NET READ >>

  • In Vitro Fertilization Increases Risk of Embolism

    JUN 3 2013OBGYN.NET READ >>

  • The Best Screening Strategies for Cervical Cancer

    JUN 7 2013OBGYN.NET READ >>

  • Nitrofurantoin is Low-Risk in Pregnancy

    MAY 27 2013OBGYN.NET READ >>

  • Primary Post-Partum Haemorrhage

    AUG 17 2011OBGYN.NET READ >>

MostPopular

  • The Relationship Between Placental Location and Fetal Gender (Ramzi’s Method)

    JUN 14 2011 OBGYN.NET READ >>

  • Daily Dx: Middle-Aged Woman with Non-specific Pelvic Pain

    JUN 4 2013 OBGYN.NET READ >>

  • Daily Dx: Three-Vessel View of a Fetal Heart

    MAY 28 2013 OBGYN.NET READ >>

  • Daily Dx: A Child with Dysuria and Pelvic Pain

    JUN 11 2013 OBGYN.NET READ >>

  • The Best Screening Strategies for Cervical Cancer

    JUN 7 2013 OBGYN.NET READ >>

  • Popular
  • Recent

Comments

  • FDA Warning: Don’t Use Magnesium Sulfate to Stop Pre-term Labor

    JUN 6 2013 OBGYN.NET READ >>

  • How do You Counsel Patients on Cord Blood Banking?

    MAY 23 2013 OBGYN.NET READ >>

  • Nitrofurantoin is Low-Risk in Pregnancy

    MAY 27 2013 OBGYN.NET READ >>

  • Poll: What do you Think of "Female Viagra"?

    NOV 20 2012 OBGYN.NET READ >>

  • Scholarly Debate

    JUN 22 2011 READ >>

Comments

  • Menopausal Medicine Is Overlooked in US Residency Programs

    MAY 13 2013 OBGYN.NET READ >>

  • Does Controlled Cord Traction Reduce Postpartum Blood Loss?

    MAY 10 2013 OBGYN.NET READ >>

  • Single Incision Surgery: Is LESS More?

    DEC 6 2011 OBGYN.NET READ >>

  • FDA Warning: Don’t Use Magnesium Sulfate to Stop Pre-term Labor

    JUN 6 2013 OBGYN.NET READ >>

  • Are Urodynamic Studies Necessary in Patients With Stress Urinary Incontinence?

    JUN 10 2013 OBGYN.NET READ >>

 

 

 

SearchMedicaSearchResult

Find peer-reviewed literature and websites for practicing medical professionals

CME on Pms And Pmdd
Evidence on Pms And Pmdd
Guidelines on Pms And Pmdd
Patient Education on Pms And Pmdd
Clinical Trials on Pms And Pmdd
Practical Articles on Pms And Pmdd
Research and Reviews on Pms And Pmdd
All "Pms And Pmdd" results

EventCalendar

  • The 5th IVI International Congress: Reproductive Medicine and Beyond by ComtecMed
    04-Apr-13 to 06-Apr-13 Seville , SPAIN (GYN - Contraception & Reproductive Health)
     
  • 2013 AIUM Annual Convention by American Institute of Ultrasound in Medicine
    06-Apr-13 to 10-Apr-13 New York (New York Marriott Marquis Hotel) , NY USA (CME - Medical Education)
     
  • Manejo clínico y terapéutico de la esterilidad. Segundo curso online by Fundacio Dexeus Salud de la Mujer
    09-Apr-13 to 31-May-13 online , SPAIN(gynecology)
     
  • Pediatric Nursing: Care of the Hospitalized Child by Continuing Education Inc.
    10-Apr-13 to 13-Apr-13 Anaheim (Hyatt Regency Orange County) , CA USA (CME - Obstetrics, Gynecology & Women's Health)
     
  • Medicina fetal Curso-Taller. Curso de Nivel I y II de la SESEGO by Fundacio Dexeus Salud de la Mujer
    15-Apr-13 to 17-Apr-13 Barcelona (Auditorio Salud de la Mujer Dexeus) , SPAIN (OB - Maternal Fetal Medicine)
     
  • Female Urology & Urogynecology Symposium (FUUS) by Quadrant HealthCom, Inc
    18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)
     
  • Female Urology and Urogynecology Symposium (FUUS) 2013 by Quadrant HealthCom, Inc
    18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy